Heightened production of inflammatory cytokines, recruitment of Th17 cells, and alterations in RANKL and osteoprotegerin (OPG) signaling could represent proposed mechanisms linking COVID-19 to osteoporosis and bone loss [174,175]. The gene discussed is TNFSF11; the disease is COVID-19.